FDA Enforcement Class II Terminated

HardyCHROM MRSA,REF; G307, LOT: 447694, A selective and differential chromogenic medium for the qualitative direct detection of nasal colonization by methicillin-resistant Staphylococcus aureus (MRSA). Not intended to diagnose infection of guide therapy. Further testing required for susceptibility or typing. Container Type: 15 x 100mm monoplate Packaged: 10 plates/sleeve STORAGE: 2-8 degree C on receipt, LIGHT SENSITIVE IVD UDI: (01)08165760201400 (10)447694 (17)191206

Recall: Z-2298-2020 · Reported June 17, 2020

Enforcement

Recall Number
Z-2298-2020
Event ID
85412
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Hardy Diagnostics
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 17, 2020
Initiation Date
November 14, 2019
Classification Date
June 8, 2020
Termination Date
April 28, 2021
Address
1430 W McCoy Ln, N/A, Santa Maria, CA, 93455-1005, United States

Description

HardyCHROM MRSA,REF; G307, LOT: 447694, A selective and differential chromogenic medium for the qualitative direct detection of nasal colonization by methicillin-resistant Staphylococcus aureus (MRSA). Not intended to diagnose infection of guide therapy. Further testing required for susceptibility or typing. Container Type: 15 x 100mm monoplate Packaged: 10 plates/sleeve STORAGE: 2-8 degree C on receipt, LIGHT SENSITIVE IVD UDI: (01)08165760201400 (10)447694 (17)191206

Reason

False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.

Code Info

Catalogue no.: G307, Lot number 447694 HDx, UDI # 00816576020140

Distribution

U.S. Distribution in the states of WI, CA, WA, IA, MT, UT, AZ, WY, KS, MO, OR, TX, VI, including PR and Guam. OUS: British Virgin Islands, Kenya,

Quantity

3,580 ea (358 kits, pack of 10 in each)